![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 417/12 | (2006.01) |
A61K 31/4439 | (2006.01) | ||
A61P 3/10 | (2006.01) |
(11) | Number of the document | 1446404 |
(13) | Kind of document | T |
(96) | European patent application number | 02779713.3 |
Date of filing the European patent application | 2002-11-21 | |
(97) | Date of publication of the European application | 2004-08-18 |
(45) | Date of publication and mention of the grant of the patent | 2006-06-14 |
(46) | Date of publication of the claims translation | 2006-11-27 |
(86) | Number | PCT/GB2002/005239 |
Date | 2002-11-21 |
(87) | Number | WO 2003/045947 |
Date | 2003-06-05 |
(30) | Number | Date | Country code |
0127931 | 2001-11-21 | GB | |
0127932 | 2001-11-21 | GB | |
0127933 | 2001-11-21 | GB |
(72) |
HO, Tim, Chien, Ting, GlaxoSmithKline, GB
MILLAN, Michael, John, GlaxoSmithKline, GB
|
(73) |
SMITHKLINE BEECHAM PLC,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Rosiglitazono edisilatai ir jų panaudojimas kaip antidiabetikų |
ROSIGLITAZONE EDISYLATES AND THEIR USE AS ANTIDIABETICS |
Payment date | Validity (years) | Amount | |
2008-10-20 | 7 | 560.00 LTL |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2009-11-21 |